Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Genome Editing Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Technology (Crispr, Zfn, Talen)
4.2.2. By Delivery Method (Ex-vivo, In-vivo)
4.2.3. By Application (Genetic Engineering, Clinical Applications)
4.2.4. By Region
4.2.5. By Company (2022)
4.3. Market Map
4.3.1. By Technology
4.3.2. By Delivery Method
4.3.3. By Application
4.3.4. By Region
5. Asia Pacific Genome Editing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Delivery Method
5.2.3. By Application
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Genome Editing Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Technology
5.3.1.2.2. By Delivery Method
5.3.1.2.3. By Application
5.3.2. India Genome Editing Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Technology
5.3.2.2.2. By Delivery Method
5.3.2.2.3. By Application
5.3.3. Australia Genome Editing Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Technology
5.3.3.2.2. By Delivery Method
5.3.3.2.3. By Application
5.3.4. Japan Genome Editing Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Technology
5.3.4.2.2. By Delivery Method
5.3.4.2.3. By Application
5.3.5. South Korea Genome Editing Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Technology
5.3.5.2.2. By Delivery Method
5.3.5.2.3. By Application
6. Europe Genome Editing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Delivery Method
6.2.3. By Application
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Genome Editing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Delivery Method
6.3.1.2.3. By Application
6.3.2. Germany Genome Editing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Delivery Method
6.3.2.2.3. By Application
6.3.3. Spain Genome Editing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Delivery Method
6.3.3.2.3. By Application
6.3.4. Italy Genome Editing Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Technology
6.3.4.2.2. By Delivery Method
6.3.4.2.3. By Application
6.3.5. United Kingdom Genome Editing Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Technology
6.3.5.2.2. By Delivery Method
6.3.5.2.3. By Application
7. North America Genome Editing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Delivery Method
7.2.3. By Application
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Genome Editing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Delivery Method
7.3.1.2.3. By Application
7.3.2. Mexico Genome Editing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Delivery Method
7.3.2.2.3. By Application
7.3.3. Canada Genome Editing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Delivery Method
7.3.3.2.3. By Application
8. South America Genome Editing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Delivery Method
8.2.3. By Application
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Genome Editing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Delivery Method
8.3.1.2.3. By Application
8.3.2. Argentina Genome Editing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Delivery Method
8.3.2.2.3. By Application
8.3.3. Colombia Genome Editing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Delivery Method
8.3.3.2.3. By Application
9. Middle East and Africa Genome Editing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Delivery Method
9.2.3. By Application
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Genome Editing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Delivery Method
9.3.1.2.3. By Application
9.3.2. Saudi Arabia Genome Editing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Delivery Method
9.3.2.2.3. By Application
9.3.3. UAE Genome Editing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Delivery Method
9.3.3.2.3. By Application
9.3.4. Egypt Genome Editing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Technology
9.3.4.2.2. By Delivery Method
9.3.4.2.3. By Application
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Delivery Method Launches
11.3. Mergers & Acquisitions
12. Global Genome Editing Market: SWOT Analysis
13. Porter?s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Delivery Method
14. Competitive Landscape
14.1. Cibus Inc
14.1.1.1. Business Overview
14.1.1.2. Company Snapshot
14.1.1.3. Delivery Method & Services
14.1.1.4. Current Capacity Analysis
14.1.1.5. Financials (In case of listed)
14.1.1.6. Recent Developments
14.1.1.7. SWOT Analysis
14.2. Recombinetics, Inc
14.3. Merck & Co., Inc
14.4. Sangamo Therapeutics Inc
14.5. Editas Medicine Inc
14.6. Precision BioSciences Inc
14.7. CRISPR Therapeutics Inc
14.8. Intellia Therapeutics, Inc
14.9. Caribou Biosciences, Inc
14.10. Takara Bio Inc
15. Strategic Recommendations
16. About Us & Disclaimer